Vcanbio Cell & Gene Engineering Corp.Ltd(600645)
Short form equity change report
Name of listed company: Vcanbio Cell & Gene Engineering Corp.Ltd(600645) place of stock listing: Shanghai Stock Exchange Stock abbreviation: Vcanbio Cell & Gene Engineering Corp.Ltd(600645) Stock Code: 600645 information disclosure obligor: China Cinda Asset Management Co., Ltd. registered address: Building 1, yard 9, naoshikou street, Xicheng District, Beijing mailing address: Building 1, yard 9, naoshikou street, Xicheng District, Beijing share change nature: decrease in the number and proportion of shares held
Signed on: January 19, 2022
Statement of information disclosure obligor
1、 This report is prepared by the information disclosure obligor in accordance with the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the content and format of information disclosure by companies offering securities to the public No. 15 – Report on changes in equity, and relevant laws, regulations and normative documents.
2、 The information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with any provision in the articles of association or internal rules of the information disclosure obligor.
3、 In accordance with the provisions of the securities law of the people’s Republic of China and the measures for the administration of the acquisition of listed companies, this report has fully disclosed the changes in the interests of the information disclosure obligor in Vcanbio Cell & Gene Engineering Corp.Ltd(600645) . As of the signing date of this report, except for the information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Vcanbio Cell & Gene Engineering Corp.Ltd(600645) by any other means.
4、 This equity change is based on the information stated in this report. Except for the information disclosure obligor, no other unit or individual has been entrusted or authorized to provide information not listed in this report and make any explanation or explanation to this report.
5、 The information disclosure obligor promises that there are no false records, misleading statements or major omissions in this report, and will bear individual and joint legal liabilities for its authenticity, accuracy and completeness.
catalogue
Section 1 interpretation Section 2 Introduction to information disclosure obligors four
1、 Basic information of information disclosure obligor four
2、 Basic information of directors and main responsible persons of information disclosure obligors 5 III. The shares of the information disclosure obligor in other domestic and overseas listed companies reach or exceed
After 5% of the issued shares of the company Section III purpose of equity change seven
1、 The purpose of this equity change of the information disclosure obligor seven
2、 Future shareholding increase plan of information disclosure obligor Section IV equity change method eight
1、 Method of this equity change eight
2、 Changes in equity this time eight
3、 Restrictions on share rights of listed companies involved in this equity change 9 Section V Trading of listed shares within the first six months Section VI other major matters Section VII documents for future reference thirteen
1、 File directory for future reference thirteen
2、 Location of documents for future reference 13 schedule fifteen
Section I interpretation
In this report, unless otherwise specified, the following words have the following meanings:
Ministry of finance means the Ministry of finance of the people’s Republic of China
CSRC refers to the China Securities Regulatory Commission
Shanghai stock exchange refers to Shanghai Stock Exchange
Vcanbio Cell & Gene Engineering Corp.Ltd(600645) / listed company means Vcanbio Cell & Gene Engineering Corp.Ltd(600645)
China Cinda / information disclosure means China Cinda Asset Management Co., Ltd
Agent / acquirer
Deyuan investor / transferor refers to Tianjin Development Zone Deyuan Investment Development Co., Ltd
Securities Law means the securities law of the people’s Republic of China
The acquisition Measures refer to the administrative measures for the acquisition of listed companies
Standard No. 15 refers to Standard No. 15 on the contents and forms of information disclosure by companies offering securities to the public – Report on changes in equity
The report and this report refer to the Vcanbio Cell & Gene Engineering Corp.Ltd(600645) simplified report on changes in equity
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
Note: any discrepancy between the total and the mantissa of the sum of the sub item values in this report is caused by rounding.
Section II introduction to information disclosure obligors
1、 Basic information of information disclosure obligor
See the following table for the basic information of information disclosure obligors:
Company name: China Cinda Asset Management Co., Ltd
Registered address: Building 1, yard 9, naoshikou street, Xicheng District, Beijing
Legal representative: Zhang ziai
The registered capital is 38164535147 yuan
Unified social credit code 91110000710924945a
Enterprise type: joint stock limited company (listed, state-owned holding)
(I) to acquire and entrust non-performing assets of financial institutions and non-financial institutions, and to manage, invest and dispose of non-performing assets; (II) conversion of creditor’s rights into equity, management, investment and disposal of equity assets; (III) bankruptcy administration; (IV) foreign investment; (V) buying and selling securities; (VI) issuing financial bonds, inter-bank borrowing and commercial financing from other financial institutions; (VII) approved asset securitization business, custody of financial institutions and liquidation business of closing business scope; (VIII) financial, investment, legal and risk management consulting and consulting;
(IX) assets and project evaluation; (x) other businesses approved by the banking regulatory authority under the State Council. (market entities shall independently select business items and carry out business activities according to law; for projects subject to approval according to law, they shall carry out business activities according to the approved contents after being approved by relevant departments; they shall not engage in business activities of projects prohibited and restricted by national and municipal industrial policies
Move.
）
Date of establishment: April 19, 1999
Operating period: April 19, 1999 to long term
Controlling shareholder Ministry of finance of the people’s Republic of China
Tel. + 86 (10) 6308000
Mailing address: Building 1, yard 9, naoshikou street, Xicheng District, Beijing
Postal Code: 100031
2、 Basic information of directors and main responsible persons of information disclosure obligors
As of the signing date of this report, the basic information of the directors and main responsible persons of China Cinda is as follows:
Name Gender nationality long-term residence whether obtained from other countries or positions
Regional residence right
Zhang Zi AI Nan, chairman of Beijing, China
Zhang Weidong, male, President of Beijing, China
He Jieping, male, non executive director of Beijing, China
Wang shaoshuang, male, no non-executive director, Beijing, China
Zhang Yuxiang, female, non executive director of Beijing, China
Zhang Guoqing, male, non executive director of Beijing, China
Liu Chongnan is a non-executive director in Shanghai, China
Chen Xiaowu, male, non executive director, Beijing, China
Zhu Wuxiang, male, Beijing, China no independent non-executive director
Sun Baowen, male, Beijing, China no independent non-executive director
Lu Zhengfei, male, Beijing, China no independent non-executive director
Lin Zhiquan, male, whether Hong Kong, China is an independent non-executive director
Luo Zhenhong, male, chief risk officer, Beijing, China
AI Jiu Chao Nan, Secretary of the board of directors, Beijing, China
Yang Yingxun, male, chief financial officer, Beijing, China
3、 Information disclosure obligor’s equity shares in other domestic and overseas listed companies reach or exceed 5% of the issued shares of the company
As of the signing date of this report, the information disclosure obligor directly holds 5% or more of the issued shares of A-share listed company:
Company name total shareholding ratio of the company’s share capital (10000 shares)
Kailuan Energy Chemical Co.Ltd(600997) 158,779.99 21.24
Company name: total shareholding ratio of the company’s share capital (10000 shares)
Ningxia Western Venture Industrial Co.Ltd(000557) 145,837.47 14.59
China Nuclear Engineering & Construction Corporation Limited(601611) 264,962.05 11.67
Zhejiang Construction Investment Group Co.Ltd(002761) 108,134.01 11.53
Liaoning Energy Industry Co.Ltd(600758) 132,201.74 9.50
Shanxi Blue Flame Holding Company Limited(000968) 96,750.27 6.03
China Cssc Holdings Limited(600150) heavy industry group power Co., Ltd. 216068.16 5.47
Jointown Pharmaceutical Group Co.Ltd(600998) 189,381.69 5.34
Section III purpose of equity change
1、 Purpose of this equity change of information disclosure obligor
This equity change is the reduction of shares of the listed company made by the information disclosure obligor for its own business development needs. 2、 Increase / decrease plan of information disclosure obligor in the next 12 months
In the next 12 months, the information disclosure obligor will decide whether to increase or decrease its shares in Vcanbio Cell & Gene Engineering Corp.Ltd(600645) according to the overall situation of the securities market and in combination with its own business development, stock price and other factors. In case of relevant equity changes, the information disclosure obligor will perform the information disclosure obligations and corresponding reporting obligations in strict accordance with the requirements of relevant laws and regulations.
Section IV changes in equity
1、 Current equity change method
After this equity change, the total shares of listed companies held by information disclosure obligors decreased from 5.20843%
Down to 4.99998%, the specific changes are as follows:
Shares held before this equity change and shares held after this equity change
Total shares of shareholders
